Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine

NCT00483717 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

173

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Ketorolac tromethamine
DRUG: Placebo

Sponsor

Egalet Ltd